Advanced Biomedical Valuation
| ABMT Stock | USD 0.0001 0.00 0.00% |
Advanced Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Advanced Biomedical from analyzing the firm fundamentals such as Shares Owned By Insiders of 3.32 %, current valuation of 3.52 M, and Return On Asset of -0.78 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Advanced Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Advanced Biomedical is based on 3 months time horizon. Increasing Advanced Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Advanced Biomedical's intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 9.6E-5 | Hype 1.12E-4 | Naive 5.5E-5 |
The intrinsic value of Advanced Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Advanced Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Advanced Biomedical Technologies helps investors to forecast how Advanced pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Advanced Biomedical more accurately as focusing exclusively on Advanced Biomedical's fundamentals will not take into account other important factors: Advanced Biomedical Total Value Analysis
Advanced Biomedical Technologies is presently expected to have valuation of 3.52 M with market capitalization of 4.14 M, debt of 6.36 M, and cash on hands of 6.98 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Advanced Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.52 M | 4.14 M | 6.36 M | 6.98 K |
Advanced Biomedical Investor Information
The company recorded a loss per share of 0.01. Advanced Biomedical had not issued any dividends in recent years. The entity had 10:1 split on the 13th of March 2009. Advanced Biomedical Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Advanced Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Advanced Biomedical has an asset utilization ratio of 26.34 percent. This implies that the Company is making $0.26 for each dollar of assets. An increasing asset utilization means that Advanced Biomedical Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Advanced Biomedical Ownership Allocation
Advanced Biomedical holds a total of 70.22 Million outstanding shares. Advanced Biomedical Technologies shows 3.32 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Advanced Biomedical Profitability Analysis
The company reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K.About Advanced Biomedical Valuation
The pink sheet valuation mechanism determines Advanced Biomedical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Advanced Biomedical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Advanced Biomedical. We calculate exposure to Advanced Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Advanced Biomedical's related companies.Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.
8 Steps to conduct Advanced Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Advanced Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Advanced Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Advanced Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Advanced Biomedical's revenue streams: Identify Advanced Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Advanced Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Advanced Biomedical's growth potential: Evaluate Advanced Biomedical's management, business model, and growth potential.
- Determine Advanced Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Advanced Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Advanced Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Advanced Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 70.1 M | |
| Retained Earnings | -10.3 M |
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.